SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024
SI-BONE (Nasdaq: SIBN), a medical device company focused on sacropelvic disorders, has announced its participation in the Piper Sandler Healthcare Conference in New York. The company's management will conduct a fireside chat on December 4, 2024, at 11:00 a.m. ET / 8:00 a.m. PT.
Investors can access the conference call through a registration link, and the live audio webcast will be available on the company's website's 'Investors' section. The webcast recording will remain accessible for replay for at least 90 days following the event.
SI-BONE (Nasdaq: SIBN), un'azienda di dispositivi medici focalizzata sui disturbi sacropelvici, ha annunciato la sua partecipazione alla Piper Sandler Healthcare Conference a New York. La direzione dell'azienda condurrà una chiacchierata informale il 4 dicembre 2024, alle 11:00 ET / 8:00 PT.
Gli investitori possono accedere alla teleconferenza tramite un link di registrazione, e la trasmissione audio in diretta sarà disponibile nella sezione 'Investitori' del sito web dell'azienda. La registrazione della trasmissione rimarrà accessibile per il replay per almeno 90 giorni dopo l'evento.
SI-BONE (Nasdaq: SIBN), una empresa de dispositivos médicos centrada en trastornos sacropelvicos, ha anunciado su participación en la Piper Sandler Healthcare Conference en Nueva York. La dirección de la empresa realizará una charla informal el 4 de diciembre de 2024, a las 11:00 a.m. ET / 8:00 a.m. PT.
Los inversores pueden acceder a la llamada de conferencia a través de un enlace de registro, y la transmisión de audio en vivo estará disponible en la sección 'Inversores' del sitio web de la empresa. La grabación de la transmisión permanecerá accesible para su reproducción durante al menos 90 días después del evento.
SI-BONE (Nasdaq: SIBN), 천골-골반 장애에 집중하는 의료 기기 회사가 뉴욕에서 열리는 Piper Sandler Healthcare Conference에 참여한다고 발표했습니다. 회사 경영진은 2024년 12월 4일 오전 11:00 ET / 오전 8:00 PT에 대화형 세션을 진행할 예정입니다.
투자자는 등록 링크를 통해 컨퍼런스 콜에 접근할 수 있으며, 실시간 오디오 웹캐스트는 회사 웹사이트의 '투자자' 섹션에서 제공될 것입니다. 웹캐스트 녹음은 이벤트 후 최소 90일 동안 재생할 수 있도록 유지됩니다.
SI-BONE (Nasdaq: SIBN), une entreprise de dispositifs médicaux axée sur les troubles sacro-pelviens, a annoncé sa participation à la Piper Sandler Healthcare Conference à New York. La direction de l'entreprise tiendra une discussion informelle le 4 décembre 2024 à 11h00 ET / 8h00 PT.
Les investisseurs peuvent accéder à la conférence téléphonique via un lien d'inscription, et le webinaire audio en direct sera disponible dans la section 'Investisseurs' du site web de l'entreprise. L'enregistrement du webinaire restera accessible en replay pendant au moins 90 jours après l'événement.
SI-BONE (Nasdaq: SIBN), ein Medizintechnikunternehmen, das sich auf sakropelvine Störungen spezialisiert hat, hat seine Teilnahme an der Piper Sandler Healthcare Conference in New York bekannt gegeben. Die Geschäftsführung des Unternehmens wird am 4. Dezember 2024 um 11:00 Uhr ET / 8:00 Uhr PT ein informelles Gespräch führen.
Anleger können über einen Registrierungslink auf den Konferenzanruf zugreifen, und das Live-Audio-Webcast wird im Bereich 'Investoren' auf der Unternehmenswebsite verfügbar sein. Die Aufzeichnung des Webcasts bleibt für mindestens 90 Tage nach der Veranstaltung zur Verfügung.
- None.
- None.
SANTA CLARA, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Piper Sandler Healthcare Conference in New York. Management will be hosting a fireside chat on Wednesday, December 4, 2024, at 11:00 a.m. Eastern Time / 8:00 a.m. Pacific Time.
Investors interested in listening to the conference call may do so by registering at this link: https://event.webcasts.com/starthere.jsp?ei=1696941&tp_key=589204a98b. Live audio of the webcast will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event.
About SI-BONE, Inc.
SI-BONE (NASDAQ: SIBN) is a global leader in technology for the surgical treatment of sacropelvic disorders. Since pioneering minimally invasive surgery of the SI joint in 2009, SI-BONE has supported over 4,000 surgeons in performing more than 110,000 sacropelvic procedures. A unique body of clinical evidence supports the use of SI-BONE’s technologies, including two randomized controlled trials and over 140 peer-reviewed publications. SI-BONE has leveraged its leadership in minimally invasive SI joint fusion to commercialize novel solutions for adjacent markets, including adult deformity, spinopelvic fixation, and pelvic trauma.
For additional information on the company or the products including risks and benefits, please visit www.si-bone.com.
iFuse Bedrock Granite, iFuse-TORQ, iFuse TORQ TNT, SI-BONE, and iFuse INTRA are registered trademarks of SI-BONE, Inc. ©2024 SI-BONE, Inc. All Rights Reserved.
Investor Contact: Saqib Iqbal investors@si-bone.com
FAQ
When is SI-BONE (SIBN) presenting at the Piper Sandler Healthcare Conference 2024?
How can investors access SI-BONE's (SIBN) presentation at the Piper Sandler Conference?
How long will SI-BONE's (SIBN) Piper Sandler Conference webcast be available for replay?
